A different approach to drug development.
We brought meaningful innovation to the pharmaceutical industry in 2008 with Quotient Sciences Translational Pharmaceutics® – a unique drug delivery platform proven to shorten development times by more than 12 months.
Integrated capabilities for drug substance, clinical testing & drug product development.
Translational Pharmaceutics® accelerates molecules through development by integrating traditionally siloed services.
Drug substance, drug product, and clinical testing activities are traditionally siloed. Oftentimes, multiple providers are selected to handle these activities, creating handovers between providers that add time and cost to the drug development process.
The Quotient Sciences Translational Pharmaceutics® platform allows us to optimize your drug development needs. By integrating those activities, we help you reach key milestones as quickly and efficiently as possible.
Understanding the dependencies between drug substance properties, formulation design, and clinical outcomes enables us to enhance development efficiency and help you achieve your goals at each development stage:
Benefits of Translational Pharmaceutics®
A faster, integrated approach to drug development.
by 12 months or more
in R&D spend
based on emerging human clinical data
to adjust formulation composition within a study
Conserves drug substance
by up to 85%
Streamlines & simplifies
vendor management & supply chain
What our customers say about Translational Pharmaceutics®
Read real insight from small and large pharmaceutical and biotech companies about their experiences working with Quotient Sciences and leveraging our Translational Pharmaceutics® platform for their drug program.
Ready to discuss how Translational Pharmaceutics® can be applied to save time and cost in your next drug program? Contact us today.
We are very excited with the results of our first human study... we have been able to leverage Quotient Sciences’ Translational Pharmaceutics® platform to gain rapid access to the clinic, helping deliver these favorable results in a smooth and rapid fashion.
Dr Simon Yaxley
Our small biotech company worked with Quotient Sciences on developing a complex formulation and validating the different iterations of the formulation in PK clinical studies using the Translational Pharmaceutics® approach. The project was successful, and we were generally impressed by the skillsets, professionalism, and courtesy of Quotient Sciences' scientists and other subject experts. We have also chosen to work with Quotient Sciences on two subsequent projects.
Leveraging an integrated compounding pharmacy approach under the Translational Pharmaceutics® platform saved us over a million dollars because we didn’t need to invest in scaling up peptide synthesis. We were able to make just the right amount of drug product needed to achieve the results we were looking for... If someone were to ask if I would work with Quotient Sciences again, I’d give them two thumbs up all the way. As a start-up biotech, you cannot underestimate how difficult it is to find the right outsourcing partner. You must have a partner that is going to be able to help you through the hard stuff and help save you as much money as possible.
"I knew that traditional manufacture and release would make it impossible for us to clinically determine the correct nafamostat component of our drug product. Quotient Sciences explained to me how their Translational Pharmaceutics® platform could reduce our development timeline by defining a design space for ER release rate, ER/IR ratio, and nafamostat dose. Additionally, they could integrate real-time adaptive manufacturing with clinical testing to rapidly test the variables within the design space and optimize the nafamostat formulation."